Tower Research Capital LLC (Trc) Zentalis Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,949 shares of ZNTL stock, worth $24,880. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,949

Previous 37,485 78.79%

Holding current value

$24,880

Previous $153,000 81.05%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.9 - $4.57 $85,654 - $134,979	-29,536 Reduced 78.79%	7,949 $29,000
Q2 2024 Aug 13, 2024	BUY	$4.09 - $16.13 $153,051 - $603,600	37,421 Added 58470.31%	37,485 $153,000
Q1 2024 May 15, 2024	SELL	$10.83 - $16.49 $38,457 - $58,555	-3,551 Reduced 98.23%	64 $1,000
Q4 2023 Feb 13, 2024	BUY	$9.84 - $20.13 $25,475 - $52,116	2,589 Added 252.34%	3,615 $54,000
Q3 2023 Nov 14, 2023	SELL	$19.63 - $28.29 $115,699 - $166,741	-5,894 Reduced 85.17%	1,026 $20,000
Q2 2023 Aug 14, 2023	BUY	$17.41 - $30.05 $84,072 - $145,111	4,829 Added 230.94%	6,920 $195,000
Q1 2023 May 09, 2023	SELL	$16.14 - $24.94 $7,860 - $12,145	-487 Reduced 18.89%	2,091 $36,000
Q4 2022 Feb 10, 2023	SELL	$18.07 - $25.6 $62,215 - $88,140	-3,443 Reduced 57.18%	2,578 $51,000
Q3 2022 Nov 10, 2022	SELL	$20.23 - $31.73 $32,752 - $51,370	-1,619 Reduced 21.19%	6,021 $130,000
Q2 2022 Aug 15, 2022	BUY	$17.91 - $52.25 $127,555 - $372,124	7,122 Added 1374.9%	7,640 $215,000
Q1 2022 May 12, 2022	SELL	$41.58 - $80.89 $142,369 - $276,967	-3,424 Reduced 86.86%	518 $24,000
Q4 2021 Feb 14, 2022	BUY	$66.92 - $84.79 $88,669 - $112,346	1,325 Added 50.63%	3,942 $331,000
Q3 2021 Nov 15, 2021	SELL	$46.83 - $73.5 $21,869 - $34,324	-467 Reduced 15.14%	2,617 $175,000
Q2 2021 Aug 16, 2021	BUY	$37.41 - $62.25 $61,352 - $102,090	1,640 Added 113.57%	3,084 $164,000
Q1 2021 May 17, 2021	BUY	$35.69 - $52.72 $25,910 - $38,274	726 Added 101.11%	1,444 $63,000
Q4 2020 Feb 16, 2021	SELL	$31.71 - $57.97 $270,042 - $493,672	-8,516 Reduced 92.22%	718 $37,000
Q3 2020 Nov 16, 2020	BUY	$27.03 - $47.97 $235,809 - $418,490	8,724 Added 1710.59%	9,234 $302,000
Q2 2020 Aug 13, 2020	BUY	$23.2 - $54.8 $11,832 - $27,948	510 New	510 $24,000

Others Institutions Holding ZNTL

# of Institutions

141

Shares Held

67.9M

Call Options Held

48.5K

Put Options Held

89.6K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $178M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Zentalis Pharmaceuticals, Inc. Transaction History